Amneal Pharmaceuticals (AMRX) - Margin dodolan resik

Simbol resmi perusahaan Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals (AMRX) production is vulnerable due to its reliance on raw material supplies from India and China. Business stability relies on the production of generics and the connection between plants and pharmacies. Quarterly sales margins demonstrate cost management efficiency, where 4.20 serves as the final level marker. Growing demand for affordable biosimilars in the US provides the company with a steady stream of orders from major distributors.

Amneal Pharmaceuticals (AMRX) - Margin dodolan resik saka 04.07.2022 nganti 20.11.2026

Amneal Corp (AMRX) - rincian metrik lan laporan keuangan

Analisis umum perusahaan:Amneal - AMRX
Produk dadi Amneal Pharmaceuticals Inc

The operational successes of Amneal Pharmaceuticals (AMRX) are directly reflected in the revenue profitability level, which demonstrates the efficiency of converting sales into net profit. This indicator measures the share of residual income after deducting all expenses, and for Amneal Pharmaceuticals (AMRX), it depends critically on the cost of raw materials from Asia and the stability of substance supply chains.

Karo sapa Amneal Pharmaceuticals saingan

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan perusahaan Perrigo Company plc|Margin dodolan resik ALVO (Alvotech Biopharmaceuticals)|LQDA: Rentabilitas dodolan resik|Galapagos N.V. - Margin dodolan resik|ANIP - Margin dodolan resik|MNKD: Margin dodolan resik|amphastar.com (AMPH) - Margin dodolan resik|PCRX (Pacira Pharmaceuticals) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ARS Pharmaceuticals, Inc. (SPRY)|Margin dodolan resik TBPH|AQST (Aquestive Therapeutics) - Tingkat bathi resik|scPharmaceuticals, Inc. - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik TECX|tonixpharma.com - Margin dodolan resik|Tingkat bathi resik SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Margin resik|Rentabilitas dodolan miturut bathi resik BioHarvest|Rentabilitas dodolan miturut bathi resik EXOZ|Rentabilitas dodolan miturut bathi resik Oramed Pharmaceuticals (ORMP)|Rentabilitas dodolan miturut bathi resik ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rentabilitas dodolan resik|Margin dodolan resik ABVC (ABVC BioPharma Inc)|CPIX - Rentabilitas dodolan miturut bathi resik|Quantum BioPharma Corp - Margin dodolan resik|FGEN (fibrogen.com) - Rentabilitas dodolan resik|TELO (Telomir Pharmaceuticals) - Rentabilitas dodolan miturut bathi resik|Rani Therapeutics Holdings - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik SNYR|Margin resik rallybio.com RLYB|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma